Prognostic implication of serum levels of IL-6 and IL-10 in children and adolescents with aggressive mature B-cell non-Hodgkin lymphoma
Authors:
Open Access
- 26 November 2025
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 26 (1)
Abstract
Aggressive mature B-cell non-Hodgkin lymphoma (B-NHL) is the most common subtype of non-Hodgkin lymphoma in children and adolescents. However, little progrKeywords
This publication has 45 references indexed in Scilit:
- Effect of body mass index on the prognosis of children and adolescents with high‐grade mature B‐cell non‐Hodgkin lymphomaCancer, 2024
- Predictive value of peripheral blood biomarkers in patients with non-small-cell lung cancer responding to anti-PD-1-based treatmentCancer Immunology, Immunotherapy, 2024
- Cytokine profiles in patients with newly diagnosed diffuse large B-cell lymphoma: IL-6 and IL-10 levels are associated with adverse clinical features and poor outcomesCytokine, 2023
- Cytokines: From Clinical Significance to QuantificationAdvanced Science, 2021
- Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancerCancer Immunology, Immunotherapy, 2018
- Immunity, Inflammation, and CancerCell, 2010
- Historical insights into cytokinesEuropean Journal of Immunology, 2007
- Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin’s lymphomaAnnals of Hematology, 2005
- Serum IL-10 and IL-6 levels at diagnosis as independent predictors of outcome in non-Hodgkin’s lymphomaJournal of Physiology and Biochemistry, 2004
- The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzleCytokine & Growth Factor Reviews, 2004